Gilad&Gilad is a privately owned, health science company with unique competency in Neuroscience. The principal mission of the Company is to develop innovative solutions and to market evidence-based safe and effective products of superior quality for healthy bodily functions. Products of our For-Nerve-HealthTM line promote healthy nervous system functions, thereby providing for a good quality of life.
We at Gilad&Gilad strive to build trust and credibility for our For-Nerve-HealthTM brand based on continuous investment in scientific research and development.
Our products are backed by solid scientific evidence and sound clinical studies. This is the 'Gilad&Gilad Principle' that earns the trust of healthcare professionals.
AgmaSet® (formerly NeurofencineTM) is our First-In-Class of dietary supplements for nerve health containing agmatine, which afford what is surely the best available solution for improving health-related nerve functions and quality of life.
- More than 20 million people in the US alone have to cope everyday with great challenges to nerve health and with threats to their nerve functions.
- Most are still unaware of AgmaSet® availability, but could greatly benefit by it.
Welcome to our Story
The foundation of our Company can be traced back to the breakthrough discovery of the neuroprotective properties of agmatine, made in 1994 by the neuroscientists founders of the Company. The discovery led Varda Gilad and Gad Gilad, who are working as a husband and wife team for many years, to propose (and patent) the use of agmatine for enhancing the capability of the nervous system to sustain harsh environmental conditions.
In 2000, the Gilads founded the Company to pursue the development of agmatine as a dietary ingredient. And in 2004, following extensive scientific research to characterize the molecular mechanisms of agmatine, they initiated the first clinical studies. These studies ended successfully in 2008 and established the safety and effectiveness of G - Agmatine® (Gilad&Gilad's proprietary trademarked brand of agmatine) for healthy nerve functions. - They have patented the use of high dosage G - Agmatine® in dietary supplements, nutraceuticals and food (including medical foods), and additional patents are pending.
In 2009, the Company set up headquarters in Los Angeles, California and established commercial production and marketing base for the exclusive For-Nerve-HealthTM product line. AgmaSet® is the Company's first dietary supplement product, while AgmaVet® is the first animal food product.
In 2017, the Company relocated its headquarters to Henderson (Las Vegas), Nevada.
Present Research Efforts - Gilad&Gilad is engaged in several clinical trials to substantiate the effectiveness of G-Agmatine® in other aspects of nervous system functions such as mood health and motor control health.
Further research activities are presently aimed at developing AgmaceuticalsTM - a series of products containing G - Agmatine® - for promoting healthy functions of additional bodily systems, including: glucose metabolism, skin structure and function, cardiovascular performance, kidney activity and more.
Please check the 'News' page for principal milestones of the Company's development.